Click to view your profile
Click to search for condition or expert
Click to open main menu
Urothelial Cancer Latest Advances
Find the Latest Research About Urothelial Cancer
Save
Bookmark
Share
Share
Overview
Find a Doctor
Latest Advances
Clinical Trials
Treatments
Customize your search results with filters
Term Search
You can select from the dropdown list OR enter your own terms to refine the search.
Last Updated: 01/06/2023
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 344 publications
See more filters
Curative effect of complete transperitoneal laparoscopic nephroureterectomy in post kidney transplantation patients with upper tract urothelial carcinoma.
Condition:
Post Kidney Transplantation Patients with Upper Tract Urothelial Carcinoma (UTUC)
Journal:
Zhonghua yi xue za zhi
Treatment Used:
Complete Transperitoneal Laparoscopic Nephroureterectomy
Number of Patients:
17
Published:
November 23, 2022
VIEW PUBLICATION
Atezolizumab for the treatment of advanced recurrent basal cell carcinoma and urothelial carcinoma of bladder: a case report.
Condition:
Advanced Recurrent Basal Cell Carcinoma and Urothelial Carcinoma of Bladder
Journal:
Journal of medical case reports
Treatment Used:
Atezolizumab
Number of Patients:
1
Published:
November 01, 2022
VIEW PUBLICATION
Disitamab vedotin, a novel HER2-directed antibody-drug conjugate in gastric cancer and other solid tumors.
Condition:
Gastric Cancer and Other Solid Tumors
Journal:
Drugs of today (Barcelona, Spain : 1998)
Treatment Used:
Disitamab Vedotin
Number of Patients:
0
Published:
October 28, 2022
VIEW PUBLICATION
A feasibility study of lenvatinib plus pembrolizumab in Japanese patients with advanced solid tumors.
Condition:
Japanese Patients with Advanced Solid Tumors
Journal:
Cancer chemotherapy and pharmacology
Treatment Used:
Lenvatinib Plus Pembrolizumab
Number of Patients:
6
Published:
October 26, 2022
VIEW PUBLICATION
Repeat Transurethral Resection of Muscle-invasive Bladder Cancer Prior to Radical Cystectomy is Prognostic but Not Therapeutic.
Condition:
Muscle-Invasive Bladder Cancer
Journal:
The Journal of urology
Treatment Used:
Repeat Transurethral Resection Prior to Radical Cystectomy
Number of Patients:
548
Published:
October 17, 2022
VIEW PUBLICATION
Management after initial surgery of nonfunctioning pituitary adenoma: surveillance, radiotherapy or surgery?
Condition:
Non-Functioning Pituitary Adenoma (NFPA)
Journal:
Radiation oncology (London, England)
Treatment Used:
Wait-and-See Approach or Salvage Radiotherapy
Number of Patients:
256
Published:
October 13, 2022
VIEW PUBLICATION
Re-Administration of Pembrolizumab for Urothelial Carcinoma after immune-Related Myasthenia Gravis : A Case Report.
Condition:
Urothelial Carcinoma after Immune-Related Myasthenia Gravis
Journal:
Hinyokika kiyo. Acta urologica Japonica
Treatment Used:
Pembrolizumab
Number of Patients:
1
Published:
October 06, 2022
VIEW PUBLICATION
The efficacy and safety of first-line treatment in cisplatin-ineligible advanced upper tract urothelial carcinoma patients: a comparison of PD-1 inhibitor and carboplatin plus gemcitabine chemotherapy.
Condition:
Advanced Upper Tract Urothelial Carcinoma (UTUC)
Journal:
Oncoimmunology
Treatment Used:
PD-1 Inhibitor
Number of Patients:
123
Published:
September 23, 2022
VIEW PUBLICATION
Second-line therapy with nivolumab plus ipilimumab for older patients with oesophageal squamous cell cancer (RAMONA): a multicentre, open-label phase 2 trial.
Condition:
Older Patients with Esophageal Squamous Cell Cancer
Journal:
The Lancet. Healthy longevity
Treatment Used:
Nivolumab Plus Ipilimumab
Number of Patients:
75
Published:
September 13, 2022
VIEW PUBLICATION
Chemotherapy following immune checkpoint inhibitors in patients with locally advanced or metastatic urothelial carcinoma.
Condition:
Locally Advanced or Metastatic Urothelial Carcinoma (la/mUC)
Journal:
European journal of cancer (Oxford, England : 1990)
Treatment Used:
Chemotherapy Following Immune Checkpoint Inhibitors (ICIs)
Number of Patients:
553
Published:
September 11, 2022
VIEW PUBLICATION
First-line pembrolizumab for patients with early relapsing urothelial carcinoma after perioperative chemotherapy: a retrospective analysis of bladder cancer and upper urinary tract cancer.
Condition:
Early Relapsing Urothelial Carcinoma
Journal:
International journal of clinical oncology
Treatment Used:
Pembrolizumab
Number of Patients:
454
Published:
August 27, 2022
VIEW PUBLICATION
Bladder-sparing trimodal therapy for muscle invasive bladder cancer.
Condition:
Muscle-Invasive Bladder Cancer
Journal:
Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique
Treatment Used:
Bladder-Sparing Trimodal Therapy
Number of Patients:
0
Published:
August 15, 2022
VIEW PUBLICATION
Showing 1-12 of 344
Next
Last Updated: 01/06/2023